1. Skip to Menu
  2. Skip to Content
  3. Skip to Footer>

lst title_en

The EuroFlow™ strategy to monitor minimal residual disease (MRD) by Next Generation Flow has been focused in B-cell precursor (BCP) acute lymphoblastic leukemia (ALL) patients.

The BCP-ALL MRD kit, designed following the fully-standardized EuroFlow™ 8-color antibody panel, allows measuring MRD and discriminating between normal and malignant BCP cells in 99% of studied BCP-ALL patients.

 

 Protected by patent

BCPALL table_en

BCPALL m_product_en

BCPALL m_product_en

BCPALL m_product_en

Description
Format
Size
Catalog code
Status
Technical Data Sheet
BCP-ALL-MRD
Lyophilized
20 tests
CYT-BCP-ALL-MRD
RUO
PDF

Pacific Blue™ is a trademark of Life Technologies Corporation

We use cookies to improve our website and your experience when using it. Cookies used for the essential operation of the site have already been set. To find out more about the cookies we use and how to delete them, see our Cookie Policy.

I accept cookies from this site.

EU Cookie Directive Module Information